3 most recent filings and news items mentioning RLAY. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/RLAY/news?limit=20"
Pull RLAY filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayRelay Therapeutics amended its certificate of incorporation to increase total authorized capital stock from an unstated prior amount to 460 million shares, comprising 450 million common shares and 10 million preferred shares. The amendment provides the company flexibility for fut
View filing at SEC.gov →Relay Therapeutics launched an underwritten public offering of approximately 22.9 million shares of common stock with an option for underwriters to purchase an additional 3.4 million shares. The offering is expected to raise approximately $996 million in gross proceeds, providing
View filing at SEC.gov →Relay announced initial Phase 2 data showing zovegalisib achieved a 60% volumetric response rate in PIK3CA-driven vascular anomalies patients at 12 weeks, with 89% investigator-reported clinical improvement and a favorable safety profile supporting chronic dosing. The positive ef
View filing at SEC.gov →